Literature DB >> 23221342

Estrogen receptor-α signaling in osteoblast progenitors stimulates cortical bone accrual.

Maria Almeida1, Srividhya Iyer, Marta Martin-Millan, Shoshana M Bartell, Li Han, Elena Ambrogini, Melda Onal, Jinhu Xiong, Robert S Weinstein, Robert L Jilka, Charles A O'Brien, Stavros C Manolagas.   

Abstract

The detection of estrogen receptor-α (ERα) in osteoblasts and osteoclasts over 20 years ago suggested that direct effects of estrogens on both of these cell types are responsible for their beneficial effects on the skeleton, but the role of ERα in osteoblast lineage cells has remained elusive. In addition, estrogen activation of ERα in osteoclasts can only account for the protective effect of estrogens on the cancellous, but not the cortical, bone compartment that represents 80% of the entire skeleton. Here, we deleted ERα at different stages of differentiation in murine osteoblast lineage cells. We found that ERα in osteoblast progenitors expressing Osterix1 (Osx1) potentiates Wnt/β-catenin signaling, thereby increasing proliferation and differentiation of periosteal cells. Further, this signaling pathway was required for optimal cortical bone accrual at the periosteum in mice. Notably, this function did not require estrogens. The osteoblast progenitor ERα mediated a protective effect of estrogens against endocortical, but not cancellous, bone resorption. ERα in mature osteoblasts or osteocytes did not influence cancellous or cortical bone mass. Hence, the ERα in both osteoblast progenitors and osteoclasts functions to optimize bone mass but at distinct bone compartments and in response to different cues.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23221342      PMCID: PMC3533305          DOI: 10.1172/JCI65910

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  47 in total

1.  Deletion of estrogen receptors reveals a regulatory role for estrogen receptors-beta in bone remodeling in females but not in males.

Authors:  N A Sims; S Dupont; A Krust; P Clement-Lacroix; D Minet; M Resche-Rigon; M Gaillard-Kelly; R Baron
Journal:  Bone       Date:  2002-01       Impact factor: 4.398

2.  Estrogens are essential for male pubertal periosteal bone expansion.

Authors:  Roger Bouillon; Marie Bex; Dirk Vanderschueren; Steven Boonen
Journal:  J Clin Endocrinol Metab       Date:  2004-12       Impact factor: 5.958

3.  Distinct roles for Hedgehog and canonical Wnt signaling in specification, differentiation and maintenance of osteoblast progenitors.

Authors:  Stephen J Rodda; Andrew P McMahon
Journal:  Development       Date:  2006-07-19       Impact factor: 6.868

4.  The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment.

Authors:  Kimihiko Sawakami; Alexander G Robling; Minrong Ai; Nathaniel D Pitner; Dawei Liu; Stuart J Warden; Jiliang Li; Peter Maye; David W Rowe; Randall L Duncan; Matthew L Warman; Charles H Turner
Journal:  J Biol Chem       Date:  2006-06-20       Impact factor: 5.157

5.  Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by beta-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT.

Authors:  Maria Almeida; Li Han; Teresita Bellido; Stavros C Manolagas; Stavroula Kousteni
Journal:  J Biol Chem       Date:  2005-10-25       Impact factor: 5.157

6.  IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice.

Authors:  Charles A O'Brien; Robert L Jilka; Qiang Fu; Scott Stewart; Robert S Weinstein; Stavros C Manolagas
Journal:  Am J Physiol Endocrinol Metab       Date:  2005-06-14       Impact factor: 4.310

7.  Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin.

Authors:  L I Plotkin; R S Weinstein; A M Parfitt; P K Roberson; S C Manolagas; T Bellido
Journal:  J Clin Invest       Date:  1999-11       Impact factor: 14.808

8.  Wnt/beta-catenin signaling is a normal physiological response to mechanical loading in bone.

Authors:  John A Robinson; Moitreyee Chatterjee-Kishore; Paul J Yaworsky; Diane M Cullen; Weiguang Zhao; Christine Li; Yogendra Kharode; Linda Sauter; Philip Babij; Eugene L Brown; Andrew A Hill; Mohammed P Akhter; Mark L Johnson; Robert R Recker; Barry S Komm; Frederick J Bex
Journal:  J Biol Chem       Date:  2006-08-14       Impact factor: 5.157

Review 9.  Skeletal sexual dimorphism: relative contribution of sex steroids, GH-IGF1, and mechanical loading.

Authors:  Filip Callewaert; Mieke Sinnesael; Evelien Gielen; Steven Boonen; Dirk Vanderschueren
Journal:  J Endocrinol       Date:  2010-08-31       Impact factor: 4.286

10.  Attenuation of the self-renewal of transit-amplifying osteoblast progenitors in the murine bone marrow by 17 beta-estradiol.

Authors:  G B Di Gregorio; M Yamamoto; A A Ali; E Abe; P Roberson; S C Manolagas; R L Jilka
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

View more
  81 in total

1.  Loss of BMPR2 leads to high bone mass due to increased osteoblast activity.

Authors:  Jonathan W Lowery; Giuseppe Intini; Laura Gamer; Sutada Lotinun; Valerie S Salazar; Satoshi Ote; Karen Cox; Roland Baron; Vicki Rosen
Journal:  J Cell Sci       Date:  2015-02-06       Impact factor: 5.285

Review 2.  Regulation of Bone Metabolism by Sex Steroids.

Authors:  Sundeep Khosla; David G Monroe
Journal:  Cold Spring Harb Perspect Med       Date:  2018-01-02       Impact factor: 6.915

3.  Metastasin S100A4 is a mediator of sex hormone-dependent formation of the cortical bone.

Authors:  Malin C Erlandsson; Li Bian; Ing-Marie Jonsson; Karin M Andersson; Maria I Bokarewa
Journal:  Mol Endocrinol       Date:  2013-06-24

4.  The Quest for Osteoporosis Mechanisms and Rational Therapies: How Far We've Come, How Much Further We Need to Go.

Authors:  Stavros C Manolagas
Journal:  J Bone Miner Res       Date:  2018-02-22       Impact factor: 6.741

5.  Non-nuclear-initiated actions of the estrogen receptor protect cortical bone mass.

Authors:  Shoshana M Bartell; Li Han; Ha-neui Kim; Sung Hoon Kim; John A Katzenellenbogen; Benita S Katzenellenbogen; Ken L Chambliss; Philip W Shaul; Paula K Roberson; Robert S Weinstein; Robert L Jilka; Maria Almeida; Stavros C Manolagas
Journal:  Mol Endocrinol       Date:  2013-02-26

6.  Emerging role of estrogen receptor-α in bone formation and bone sparing.

Authors: 
Journal:  Bonekey Rep       Date:  2013-04-17

7.  Estrogens and selective estrogen receptor modulators differentially antagonize Runx2 in ST2 mesenchymal progenitor cells.

Authors:  Yonatan Amzaleg; Jie Ji; Donlaporn Kittivanichkul; Anna E Törnqvist; Sara Windahl; Elias Sabag; Aysha B Khalid; Hal Sternberg; Michael West; John A Katzenellenbogen; Susan A Krum; Nyam-Osor Chimge; Dustin E Schones; Yankel Gabet; Claes Ohlsson; Baruch Frenkel
Journal:  J Steroid Biochem Mol Biol       Date:  2018-05-08       Impact factor: 4.292

8.  Sex-Dependent, Osteoblast Stage-Specific Effects of Progesterone Receptor on Bone Acquisition.

Authors:  Zhendong A Zhong; Alexander Kot; Yu-An E Lay; Hongliang Zhang; Junjing Jia; Nancy E Lane; Wei Yao
Journal:  J Bone Miner Res       Date:  2017-07-13       Impact factor: 6.741

Review 9.  The role of estrogen and androgen receptors in bone health and disease.

Authors:  Stavros C Manolagas; Charles A O'Brien; Maria Almeida
Journal:  Nat Rev Endocrinol       Date:  2013-09-17       Impact factor: 43.330

10.  A comparative study of Sr-incorporated mesoporous bioactive glass scaffolds for regeneration of osteopenic bone defects.

Authors:  L Wei; J Ke; I Prasadam; R J Miron; S Lin; Y Xiao; J Chang; C Wu; Y Zhang
Journal:  Osteoporos Int       Date:  2014-05-08       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.